-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gedatolisib in Head And Neck Cancer Squamous Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gedatolisib in Head And Neck Cancer Squamous Cell Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Gedatolisib in Head And Neck Cancer Squamous Cell...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gedatolisib in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gedatolisib in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Gedatolisib in Triple-Negative Breast Cancer (TNBC) Drug Details:Gedatolisib (PF-05212384, PKI-587) is...
-
Product Insights
NewCelcuity Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Celcuity Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Celcuity Inc (Celcuity) is a cellular analysis company. It develops companion diagnostic tests to identify new patient populations for targeted therapies. The company’s CELx signaling function diagnostic platform utilizes a patient’s living tumor cells to identify the specific abnormal cellular activity. It also develops CELx multi-pathway (MP) signaling function test for breast cancer which measures HER1, HER2, HER3, and c-Met...
-
Product Insights
Net Present Value Model: Gedatolisib
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Gedatolisib Drug Details Gedatolisib (PF-05212384, PKI-587)...
-
Product Insights
Small-Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Small cell lung cancer (SCLC) is the most aggressive form of lung cancer. These tumors often spread rapidly (metastasize) to other parts of the body, including the brain, liver, and bone. The Small-Cell Lung Cancer market research report provides comprehensive information on the therapeutics under development for SCLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its...
-
Product Insights
Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Prostate cancer usually occurs in older men. Its symptoms include problems while urinating, decreased force in the stream of urine, blood in the urine, pain in the lower back, hips, or thighs, bone pain, and erectile dysfunction. The Prostate Cancer pipeline market research report provides comprehensive information on the therapeutics under development for Prostate Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – gedatolisib
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry gedatolisib Drug Details Gedatolisib (PF-05212384, PKI-587) is under development for ER+/HER2-negative metastatic breast cancer,...
-
Product Insights
Clinical Chemistry Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Clinical chemistry rapid tests are used in low-resource settings with the help of test strips, tablets, and solutions. Clinical chemistry PoC diagnostics are used to determine the concentration or activity of blood gas, electrolytes, metabolites, enzymes, carbohydrates, proteins, lipids, and small molecules. The Clinical Chemistry Rapid Tests and POC pipeline market research report provides comprehensive information about the Clinical Chemistry Rapid Tests and POC pipeline products with a comparative analysis of the products at various stages of development and information...
-
Product Insights
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Head and Neck Cancer Pipeline Drugs Market Report Overview Head and Neck Cancer symptoms include persistent pain in the throat, pain or difficulty with swallowing, persistent hoarseness or a change in voice, pain in the ear and bleeding in the mouth or throat. Treatment includes chemotherapy and radiation therapy. The Head and Neck Cancer pipeline drugs market research report provides an analysis of the Head and Neck Cancer drugs by stage of development, drug target, mechanism of action (MoA), route...
-
Product Insights
Ovarian Cancer Diagnostic Tests – Medical Devices Pipeline Assessment, 2020
Ovarian Cancer Diagnostic Tests include assays of mostly antibodies released in response to a ovarian cancer and cancer-causing proteins. GlobalData's Medical Devices sector report, “Ovarian Cancer Diagnostic Tests-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Ovarian Cancer Diagnostic Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Ovarian Cancer Diagnostic Tests Pipeline Assessment report provides key information and data related to: Extensive...